Late-Disease Stage at Presentation to an HIV Clinic in the Era of Free Antiretroviral Therapy in Sub-Saharan Africa

被引:122
作者
Kigozi, Isaac M.
Dobkin, Loren M. [1 ]
Martin, Jeffrey N. [2 ]
Geng, Elvin H. [1 ]
Muyindike, Winnie [3 ]
Emenyonu, Nneka I. [4 ]
Bangsberg, David R. [4 ]
Hahn, Judith A. [1 ]
机构
[1] Univ Calif San Francisco, Div Infect Dis, San Francisco Gen Hosp, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[3] Mbarara Univ Sci & Technol, Fac Med, Mbarara, Uganda
[4] Harvard Univ, Sch Med, Harvard Initiat Global Hlth, Massachusetts Gen Hosp, Boston, MA USA
基金
美国国家卫生研究院;
关键词
antiretroviral therapy; access; sub-Saharan Africa; late presentation; CD4 CELL COUNTS; LATE DIAGNOSIS; MEDICAL-CARE; HIV-1-INFECTED PATIENTS; SOUTH-AFRICA; COLLABORATIVE ANALYSIS; SEROSTATUS DISCLOSURE; ALCOHOL-CONSUMPTION; INFECTED PERSONS; UNITED-STATES;
D O I
10.1097/QAI.0b013e3181ab6eab
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Access to free antiretroviral therapy in sub-Saharan Africa has been steadily increasing, and the success of large-scale antiretroviral therapy programs depends on early initiation of HIV care. However, little is known about the stage at which those infected with HIV present for treatment in sub-Saharan Africa. Methods: We conducted a cross-sectional analysis of initial visits to the Immune Suppression Syndrome Clinic of the Mbarara University Teaching Hospital, including patients who had their initial visit between February 2007 and February 2008 (N = 2311). Results: The median age of the patients was 33 years (range 16-81 years), and 64% were female. More than one third (40%) were categorized as late presenters, that is, World Health Organization disease stage 3 or 4. Male gender, age 46-60 years (vs. younger), lower education level, being unemployed, living in a household with others, being unmarried, and lack of spousal HIV status disclosure were independently associated with late presentation, whereas being pregnant, having young children, and consuming alcohol in the prior year were associated with early presentation. Conclusions: Targeted public health interventions to facilitate earlier entry into HIV care are needed, as well as additional study to determine whether late presentation is due to delays in testing vs. delays in accessing care.
引用
收藏
页码:280 / 289
页数:10
相关论文
共 50 条
  • [21] Differentiated HIV care in sub-Saharan Africa: a scoping review to inform antiretroviral therapy provision for stable HIV-infected individuals in Kenya
    Hagey, Jill M.
    Li, Xuan
    Barr-Walker, Jill
    Penner, Jeremy
    Kadima, Julie
    Oyaro, Patrick
    Cohen, Craig R.
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2018, 30 (12): : 1477 - 1487
  • [22] Pediatric Access and Continuity of HIV Care Before the Start of Antiretroviral Therapy in Sub-Saharan Africa
    Bastard, Mathieu
    Poulet, Elisabeth
    Nicolay, Nathalie
    Szumilin, Elisabeth
    Balkan, Suna
    Pujades-Rodriguez, Mar
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (09) : 981 - 986
  • [23] Commentary: Early antiretroviral therapy for HIV infection in sub-Saharan Africa, a challenging new step
    Christian Laurent
    Journal of Public Health Policy, 2010, 31 : 401 - 406
  • [24] Adherence to antiretroviral therapy among HIV-1 patients from sub-Saharan Africa: a systematic review
    Almeida, Pedro R. S.
    Rafael, Carlos A. C.
    Pimentel, Victor
    Abecasis, Ana B.
    Sebastiao, Cruz S.
    de Morais, Joana
    AIDS REVIEWS, 2024, 26 (03) : 102 - 110
  • [25] Disparities in Oral Cancer Stage at Presentation in a High HIV Prevalence Setting In Sub-Saharan Africa
    Motlokwa, Precious K.
    Tsima, Billy M.
    Martei, Yehoda M.
    Ralefala, Tlotlo
    Galebole, Faith
    Stephens-Shields, Alisa J.
    Grover, Surbhi
    Gross, Robert
    JCO GLOBAL ONCOLOGY, 2022, 8 : e2100439
  • [26] Interventions to reduce mortality in sub-Saharan Africa among HIV-infected adults not yet on antiretroviral therapy
    Peterson, Kevin
    van Griensven, Johan
    in 't Veld, Diana Huis
    Colebunders, Robert
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2012, 10 (01) : 43 - 50
  • [27] Cost of Differentiated HIV Antiretroviral Therapy Delivery Strategies in Sub-Saharan Africa: A Systematic Review
    Roberts, D. Allen
    Tan, Nicholas
    Limaye, Nishaant
    Irungu, Elizabeth
    Barnabas, Ruanne V.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2019, 82 : S339 - S347
  • [28] Association between Antiretroviral Therapy and Cancers among Children Living with HIV in Sub-Saharan Africa
    Haq, Heather
    Elyanu, Peter
    Bulsara, Shaun
    Bacha, Jason M.
    Campbell, Liane R.
    El-Mallawany, Nader K.
    Keating, Elizabeth M.
    Kisitu, Grace P.
    Mehta, Parth S.
    Rees, Chris A.
    Slone, Jeremy S.
    Kekitiinwa, Adeodata R.
    Matshaba, Mogomotsi
    Mizwa, Michael B.
    Mwita, Lumumba
    Schutze, Gordon E.
    Wanless, Sebastian R.
    Scheurer, Michael E.
    Lubega, Joseph
    CANCERS, 2021, 13 (06) : 1 - 11
  • [29] No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa
    Gill, CJ
    Hamer, DH
    Simon, JL
    Thea, DA
    Sabin, LL
    AIDS, 2005, 19 (12) : 1243 - 1249
  • [30] Challenges and perspectives of compliance with pediatric antiretroviral therapy in Sub-Saharan Africa
    Dahourou, D. L.
    Leroy, V.
    MEDECINE ET MALADIES INFECTIEUSES, 2017, 47 (08): : 511 - 518